Mesothelioma is extremely rare. In 2022, just 2,669 new cases were reported in the United States, translating to roughly 0.65 cases per 100,000 people. To put that in perspective, the U.S. sees about 2 million total cancer diagnoses each year, making mesothelioma responsible for roughly 0.1% of them.
How It Compares to Other Cancers
Globally, mesothelioma ranks 32nd among all cancer types, with about 30,870 cases diagnosed worldwide in 2022. Breast cancer, by comparison, produces over 2 million new cases per year. Even cancers most people consider uncommon, like thyroid or testicular cancer, are diagnosed many times more often than mesothelioma. The global age-standardized rate is just 0.28 per 100,000, meaning that in a city of 350,000 people, you’d statistically expect about one new case per year.
Where Mesothelioma Is Most Common
Mesothelioma clusters in industrialized countries that used asbestos heavily during the 20th century. Europe accounts for nearly half (48%) of all global cases, followed by Asia at 28% and North America at about 13%. Australia and New Zealand have the highest per-capita rates in the world, with an age-standardized incidence of 1.2 per 100,000 in men and 2.0 per 100,000 in women. Northern Europe, particularly the United Kingdom and Luxembourg, also reports elevated rates.
These geographic patterns directly trace back to historical asbestos mining, manufacturing, and construction. Countries that banned asbestos earlier are beginning to see their rates plateau or decline, but because the disease takes decades to develop after exposure, the full impact of past use is still unfolding.
Who Gets It: Age and Gender Patterns
Men develop mesothelioma about 2.5 times more often than women, largely because occupational asbestos exposure was concentrated in male-dominated industries like shipbuilding, construction, and mining. In a large Italian registry of over 21,000 cases, the female-to-male ratio was 0.40 overall, dropping to just 0.14 among cases linked specifically to workplace exposure.
Women tend to be diagnosed at slightly older ages than men. For pleural mesothelioma (the most common form), the average age at diagnosis is around 70.5 years for women versus 68.8 years for men with occupational exposure. Women’s cases are more often tied to secondhand or environmental exposure, such as washing a family member’s work clothes or living near asbestos-contaminated sites.
The Asbestos Connection and Its Exceptions
About 80% of mesothelioma cases have a documented history of asbestos exposure. The remaining 20% occur in people with no identifiable contact with asbestos, though some of those cases may involve exposure the patient simply didn’t recognize or remember. Other potential causes include radiation therapy to the chest and exposure to erionite, a naturally occurring mineral fiber found in certain volcanic rock formations.
One of the reasons mesothelioma can seem to appear “out of nowhere” is its extraordinarily long latency period. The time between first asbestos exposure and diagnosis typically ranges from 20 to 40 years, and cases have been documented as late as 71 years after initial exposure. Someone exposed at a summer construction job in their twenties might not develop symptoms until their seventies or eighties.
Some Types Are Rarer Than Others
Not all mesotheliomas are equal in frequency. The cancer arises from the thin lining that surrounds internal organs, and the location determines the type:
- Pleural mesothelioma (lining of the lungs) accounts for about 95% of all cases. This is what most people mean when they refer to mesothelioma.
- Peritoneal mesothelioma (lining of the abdomen) makes up roughly 5% of cases.
- Pericardial mesothelioma (lining of the heart) and mesothelioma of the tunica vaginalis (a membrane around the testes) occur only sporadically, each representing well under 1% of diagnoses.
There are also histological subtypes that are exceptionally uncommon even within this already rare disease. Well-differentiated papillary peritoneal mesothelial tumors, for example, are so infrequent that they remain understudied. These tumors behave very differently from typical mesothelioma. In long-term follow-up, no patients with this subtype required systemic treatment, and no disease-specific deaths were observed.
Survival Rates Vary Dramatically by Type
Mesothelioma’s rarity contributes to its poor prognosis: fewer cases means less clinical trial data and fewer treatment breakthroughs compared to common cancers. The national average five-year survival rate for pleural mesothelioma is about 12%. Pericardial mesothelioma is even grimmer, at roughly 9%.
Peritoneal mesothelioma is the exception. Its five-year survival rate reaches approximately 65%, partly because it responds better to heated chemotherapy delivered directly into the abdomen during surgery. Specialized cancer centers may achieve even higher numbers. Moffitt Cancer Center, for instance, reports an overall five-year survival rate of 17.3% for advanced-stage mesothelioma across all types, which is notably above the national average for pleural cases.
Why Cases Continue Despite Bans
Many countries have restricted or banned asbestos, yet new cases keep appearing. The primary reason is the decades-long latency period. People exposed in the 1970s and 1980s are only now reaching the window where disease is most likely to develop. In the U.S., new cases can also arise from maintenance, demolition, or renovation of older buildings that still contain asbestos materials, particularly when proper safety controls aren’t in place.
Globally, asbestos is still mined and used in parts of Asia, Africa, and South America. Public health experts expect the global burden to gradually shift toward these regions as their exposure histories catch up. In industrialized nations with early bans, incidence is expected to slowly decline over the coming decades as the exposed population ages out, but the disease will not disappear entirely given the percentage of cases with no clear asbestos link.